Cargando…
Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption
In this study, Cas9 system was employed to down-regulate mdr1 gene for overcoming multidrug resistance of cancer cells. Disruption of the MDR1 gene was achieved by delivery of the Cas9-sgRNA plasmid or the Cas9-sgRNA ribonucleoprotein complex using a conventional gene transfection agent and protein...
Autores principales: | Ha, Jong Seong, Byun, Juyoung, Ahn, Dae-Ro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785396/ https://www.ncbi.nlm.nih.gov/pubmed/26961701 http://dx.doi.org/10.1038/srep22847 |
Ejemplares similares
-
Recyclable CRISPR/Cas9 mediated gene disruption and deletions in Histoplasma
por: Joehnk, Bastian, et al.
Publicado: (2023) -
Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016) -
Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction
por: Xia, Emily, et al.
Publicado: (2018) -
CRISPR-Cas9-Mediated Single-Gene and Gene Family Disruption in Trypanosoma cruzi
por: Peng, Duo, et al.
Publicado: (2014) -
Development of CRISPR/Cas9-mediated gene disruption systems in Giardia lamblia
por: Lin, Zi-Qi, et al.
Publicado: (2019)